Paragon 28
-
Extremities
Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024
Stephen Deitsch resigns from his position as Chief Financial Officer to pursue another opportunity; Kristina Wright appointed interim Chief Financial…
Read More » -
Extremities
Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair System
Figure 1: Anterior inferior tibiofibular ligament (“AITFL”) Repair Showing the Grappler® R3INFORCE™ Dynamic Anchor (left) and Grappler® Knotless Anchor (center).…
Read More » -
Extremities
Paragon 28 Launches PRECISION® MIS Bunion System Offering Surgeons a Guided Minimally Invasive Surgical Solution for Treating Patients with Bunions
ENGLEWOOD, Colo., February 1, 2024 –(BUSINESS WIRE)– Paragon 28, Inc. (NYSE: FNA) is pleased to announce the launch of the…
Read More » -
Extremities
Paragon 28 Announces the Launch of the FJ2000™ Power Console and Burr System Designed Specifically for Foot and Ankle Procedures
ENGLEWOOD, Colo., January 24, 2024 –(BUSINESS WIRE)– Paragon 28, Inc. (NYSE: FNA) is proud to announce a novel solution in…
Read More » -
Extremities
Paragon 28 Announces First Cases and Limited Market Release of the Bun-Yo-Matic™ – A Next Generation Clamp and Cut Guide System for Lapidus Bunion Procedures
ENGLEWOOD, Colo., January 17, 2024–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA), is excited to announce the limited market release of its…
Read More » -
Financial
Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023
ENGLEWOOD, Colo., January 8, 2024–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “P28”), a leading medical device company exclusively…
Read More » -
Extremities
Paragon 28 Advances Foot and Ankle Specific Soft Tissue Portfolio with Launch of Grappler® Knotless Anchor System and Innovative Bridgeline™ Tape
ENGLEWOOD, Co., January 5, 2024 –(BUSINESS WIRE)– Paragon 28, Inc. (NYSE: FNA), is thrilled to announce the launch of the…
Read More » -
Financial
Paragon 28 Announces New $150 Million Credit Facility Replacing Existing $90 Million Credit Facility
ENGLEWOOD, Colo., November 7, 2023–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “Company”), a leading medical device company exclusively…
Read More » -
Financial
Paragon 28 Reports Third Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance
ENGLEWOOD, Colo., November 7, 2023–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “Company”), a leading medical device company exclusively…
Read More » -
Financial
Paragon 28 Reports Second Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance
ENGLEWOOD, Colo., August 2, 2023–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “Company”), a leading medical device company exclusively…
Read More »